Nuo Therapeutics
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Nuo Therapeutics's past years’ income statements indicate that its last revenue has increased compared to the previous period by 442% to $608,525. Profit margin reached -521%. Total operating expenses were $3,650,707.
Profit Margin
| 2014 | 7.76M | -18.88M | -243.28% |
|---|---|---|---|
| 2015 | 11.51M | -52.80M | -458.76% |
| 2016 | 2.20B | 0 | |
| 2017 | 721.04K | -14.97M | -2077.36% |
| 2018 | 1.37M | -1.54M | -112.49% |
| 2019 | 146.17K | -1.41M | -968.93% |
| 2020 | 0 | -139.26K | |
| 2021 | 0 | -90.67K | |
| 2022 | 112.25K | -3.02M | -2695.14% |
| 2023 | 608.52K | -3.17M | -521.17% |
AURX Income Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||
Revenue | 608.52K | 112.25K | 0 | 0 | 146.17K | 1.37M | 721.04K | 2.20B | 11.51M | 7.76M |
Cost of revenue | 126.09K | 19.21K | 0 | 0 | 114.61K | 162.99K | 1.09M | 1.61B | 7.96M | 6.77M |
Gross profit | 482.43K | 93.03K | 0 | 0 | 31.56K | 1.20M | -369.99K | 592M | 3.54M | 991.19K |
Operating exp. | ||||||||||
Research and development | 0 | 0 | 0 | 0 | 181.18K | 576.19K | 1.32M | 0 | 2.55M | 2.62M |
Selling and marketing | 0 | 0 | 0 | 0 | 30.45K | 114.87K | 712.73K | 0 | 6.23M | 5.77M |
Total operating expenses | 3.65M | 3.41M | 90.67K | 378.05K | 1.00M | 2.71M | 5.86M | 0 | 17.80M | 19.69M |
Operating income | -3.16M | -3.32M | -90.67K | -378.05K | -969.19K | -1.50M | -15.53M | 592M | -41.31M | -23.39M |
Other income (expenses), net | -3.16K | 148.85K | 287.18B | 287.18K | -225.69K | 1.76K | 555.49K | 0 | -11.57M | 4.52M |
Income before tax | -3.17M | -3.17M | -90.67K | -90.87K | -1.19M | -1.54M | -14.97M | 0 | -52.89M | -18.86M |
Income tax expense | 0 | -146.43K | 287.18B | 48.39K | 221.45K | 37.12K | -555.49K | 0 | -89.01K | 19.58K |
Net income | -3.17M | -3.02M | -90.67K | -139.26K | -1.41M | -1.54M | -14.97M | 0 | -52.80M | -18.88M |
Earnings per share | ||||||||||
Basic EPS | -0.07 | -0.07 | -0.00 | -0.00 | -0.05 | -0.06 | -1.02 | 0 | -0.42 | -0.16 |
Diluted EPS | -0.07 | -0.07 | -0.00 | -0.00 | -0.05 | -0.06 | -1.02 | 0 | -0.42 | -0.16 |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |